‘Embrace the future’ of robotics in ophthalmology
Click here to read the At Issue to this Healio Exclusive.When new technology is developed, even one that seems revolutionary…
Click here to read the At Issue to this Healio Exclusive.When new technology is developed, even one that seems revolutionary…
WASHINGTON — The general population may not be as educated about the prevalence of dry eye disease or its impact…
Patients with glaucoma displayed impaired reading performance and increased saccades, according to a cross-sectional study published in Journal of Glaucoma.“The…
KIAWAH ISLAND, S.C. — In this video from Kiawah Eye & Retina, Beeran B. Meghpara, MD, highlights the benefits of…
The FDA approved Lytenava for the treatment of neovascular age-related macular degeneration, according to a press release from Outlook Therapeutics.The…
LAS VEGAS — Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy, according to a presentation…
The first patient has been enrolled in the phase 3 Galassia-NAION-301 study to evaluate an intranasal spray for the treatment…
The WHO 2019 report on vision estimates that 36 million people in the world are blind and another 217 million…
Healio AI and the American Society of Cataract and Refractive Surgery, or ASCRS, announced a partnership to optimize available educational…
Click here to read the Point/Counter to this Cover Story.Through the combined efforts of local governments, pioneering institutions, global health…
The FDA favorably reviewed plans for a phase 3 trial of urcosimod, which is being investigated for the treatment of…
More than 2.5 million bottles of steroid eye drops aimed at relieving inflammation have been recalled, according to the FDA.Lupin…
Healio has garnered six APEX awards, including one Grand Award, this year.The APEX awards highlight outstanding achievement in graphic design,…
AMA recently reiterated its call for Congress to pass several reforms that would increase physician payment and improve health care…
PHOENIX — A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according…